LDN 2017 Conference - Saturday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Saturday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Afternoon Q&A (2017 Conference) (LDN, low dose naltrexone)

LDN 2017 Conference - Friday Morning Q&A (2017 Conference) (LDN, low dose naltrexone)

Paul Anderson, NMD - Immune Therapies for Multiple Sclerosis (2017 Conference) (LDN, low dose naltrexone)

How LDN can be so successful in treating Multiple Sclerosis (MS) by boosting the immune system and improving the overall wellbeing of the patient.

Mark Shukhman, MD - LDN for treatment of Postcoital Dysphoria (2017 Conference) (LDN, low

Dr Shukhman explains the impact that LDN can have upon the body’s sex hormones in terms of psychology and performance.

Jill Cottel, MD - LDN for Alcohol Use Disorder (2017 Conference) (LDN, low dose naltrexone)

Dr Jill Cottel: Hello everyone. This is Dr Jill Cottell. I'm an internal medicine doctor from Poway in California. As always, it is my pleasure and privilege to work with the LDN Research Trust.

Jill Brook, MA - What the Bleep Can I Eat?! Making Sense of Conflicting Autoimmune Diets (2017 Conference) (LDN, low dose naltrexone)

Leonard Weinstock, MD - Inflammatory Bowel Disease I (2017 Conference) (LDN, low dose naltrexone)

Ginevra Liptan, MD - Alternative Strategies for Fibromyalgia Pain (2017 Conference) (LDN, low dose naltrexone)